Tag: Prescription Drugs
ACE Inhibitors, ARBs Not Linked to In-Hospital COVID-19 Death
Risk for in-hospital death increased with age >65, underlying cardiovascular disease, COPD, smoking
Guideline Issued for Nonsevere, Severe COVID-19 Therapy
Corticosteroids recommended for severe COVID-19 with ARDS but not severe COVID-19 without ARDS
Yoga + Medical Care Better for Episodic Migraines
Improvement seen in headache frequency, intensity, pill count, disability assessments
L-Thyroxine Does Not Improve Subclinical Hypothyroidism in ≥65s
No improvement seen in hypothyroid symptoms, tiredness versus placebo in older adults with SCH
ACE Inhibitors, ARBs Not Linked to Risk for COVID-19
And, not one of five classes of anti-HTN meds linked to increased likelihood of positive COVID-19 test
Guidelines Issued for Managing Eosinophilic Esophagitis
Topical glucocorticosteroids recommended over no treatment
Genomically Targeted Treatment Slows Advanced Prostate Cancer
Men receiving olaparib versus standard treatment experience delayed disease progression
Hydroxychloroquine in COVID-19 Ups Risk for QTc Prolongation
Concurrent treatment with azithromycin linked to greater changes in corrected QT interval
Testing, Prescribing Increase After Change to TSH Reference Range
Levothyroxine prescriptions, TSH measurements increased after upper limit of normal for TSH lowered
Evolocumab Does Not Impact Cognition in Atherosclerotic CVD
Adding evolocumab to maximally tolerated statin therapy did not affect patient-reported cognition
